DermTech, Inc.

Informe acción NasdaqCM:DMTK

Capitalización de mercado: US$21.8m

DermTech Dirección

Dirección controles de criterios 0/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Bret Christensen

Chief Executive Officer (CEO)

US$1.9m

Compensación total

Porcentaje del salario del CEO20.2%
Permanencia del CEOless than a year
Participación del CEOn/a
Permanencia media de la dirección1.8yrs
Promedio de permanencia en la Junta Directiva2.6yrs

Actualizaciones recientes de la dirección

Recent updates

We're A Little Worried About DermTech's (NASDAQ:DMTK) Cash Burn Rate

Mar 02
We're A Little Worried About DermTech's (NASDAQ:DMTK) Cash Burn Rate

Investors Don't See Light At End Of DermTech, Inc.'s (NASDAQ:DMTK) Tunnel And Push Stock Down 28%

Mar 02
Investors Don't See Light At End Of DermTech, Inc.'s (NASDAQ:DMTK) Tunnel And Push Stock Down 28%

Revenues Working Against DermTech, Inc.'s (NASDAQ:DMTK) Share Price

Dec 28
Revenues Working Against DermTech, Inc.'s (NASDAQ:DMTK) Share Price

Companies Like DermTech (NASDAQ:DMTK) Could Be Quite Risky

Sep 18
Companies Like DermTech (NASDAQ:DMTK) Could Be Quite Risky

Can DermTech (NASDAQ:DMTK) Afford To Invest In Growth?

Jun 14
Can DermTech (NASDAQ:DMTK) Afford To Invest In Growth?

Need To Know: The Consensus Just Cut Its DermTech, Inc. (NASDAQ:DMTK) Estimates For 2023

May 10
Need To Know: The Consensus Just Cut Its DermTech, Inc. (NASDAQ:DMTK) Estimates For 2023

DermTech, Inc. (NASDAQ:DMTK) Not Doing Enough For Some Investors As Its Shares Slump 37%

May 06
DermTech, Inc. (NASDAQ:DMTK) Not Doing Enough For Some Investors As Its Shares Slump 37%

We're Keeping An Eye On DermTech's (NASDAQ:DMTK) Cash Burn Rate

Jan 16
We're Keeping An Eye On DermTech's (NASDAQ:DMTK) Cash Burn Rate

Analyst Forecasts Just Became More Bearish On DermTech, Inc. (NASDAQ:DMTK)

Nov 08
Analyst Forecasts Just Became More Bearish On DermTech, Inc. (NASDAQ:DMTK)

Will DermTech (NASDAQ:DMTK) Spend Its Cash Wisely?

Oct 11
Will DermTech (NASDAQ:DMTK) Spend Its Cash Wisely?

DermTech grants stock options

Oct 11

Diving Into DermTech

Sep 01

Earnings Release: Here's Why Analysts Cut Their DermTech, Inc. (NASDAQ:DMTK) Price Target To US$23.80

Aug 10
Earnings Release: Here's Why Analysts Cut Their DermTech, Inc. (NASDAQ:DMTK) Price Target To US$23.80

DermTech: Approaching An All Or Nothing Moment

Jun 13

We're Keeping An Eye On DermTech's (NASDAQ:DMTK) Cash Burn Rate

Jun 04
We're Keeping An Eye On DermTech's (NASDAQ:DMTK) Cash Burn Rate

DermTech - Taking A Second Look At The Growth Thesis

Mar 31

DermTech: Adoption Headwinds And Earnings Misses

Dec 23

Companies Like DermTech (NASDAQ:DMTK) Are In A Position To Invest In Growth

Dec 02
Companies Like DermTech (NASDAQ:DMTK) Are In A Position To Invest In Growth

DermTech - Game Changer, Set To Become The Leader In Skin Diagnostics

Sep 15

We Think DermTech (NASDAQ:DMTK) Can Afford To Drive Business Growth

Sep 03
We Think DermTech (NASDAQ:DMTK) Can Afford To Drive Business Growth

DermTech: Transforming The Melanoma Diagnosis Landscape

Aug 31

DermTech: Becoming More Appealing, Despite Nosebleed Valuation

Aug 09

DermTech appoints former Myriad Genetics executive as new chief medical officer

Jun 16

We're Not Very Worried About DermTech's (NASDAQ:DMTK) Cash Burn Rate

Jun 05
We're Not Very Worried About DermTech's (NASDAQ:DMTK) Cash Burn Rate

DermTech initiated buy at BTIG on the potential of PLA test

May 03

DermTech rises 18% on report Cigna covering early melanoma detection test

Apr 27

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Bret Christensen en comparación con los beneficios de DermTech?
FechaCompensación totalSalarioIngresos de la empresa
Dec 31 2023US$2mUS$389k

-US$101m

Compensación vs. Mercado: La compensación total de Bret($USD1.93M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD670.12K).

Compensación vs. Ingresos: Datos insuficientes para comparar la compensación de Bret con los resultados de la empresa.


CEO

Bret Christensen (52 yo)

less than a year

Permanencia

US$1,928,967

Compensación

Mr. Bret Christensen serves as Chief Executive Officer, President and Director at DermTech, Inc. since May 08, 2023. He serves as Director of Axena Health, Inc. Mr. Christensen had been Chief Commercial Of...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Bret Christensen
Presidentless than a yearUS$1.93msin datos
Kevin Sun
CFO, Treasurer & Secretary4.7yrsUS$934.85k0.79%
$ 172.8k
Ray Akhavan
General Counsel3.3yrsUS$818.76k0.17%
$ 36.2k
William Zondler
Chief Information Officer1.6yrssin datossin datos
Steve Kunszabo
Senior Director of Investor Relationsno datasin datossin datos
Jennifer Eilemberg
Chief Compliance Officer1.8yrssin datossin datos
Burkhard Jansen
Chief Medical Affairs Officer7.3yrsUS$480.83ksin datos
Loren Clarke
Chief Medical Officer2.9yrssin datossin datos
Steven Stone
Senior Vice President of Research & Development1.8yrssin datossin datos
Mark Aguillard
Chief Commercial Officerless than a yearsin datossin datos

1.8yrs

Permanencia media

52yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de DMTK no se considera experimentado ( 1.8 años antigüedad media), lo que sugiere un nuevo equipo.


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Bret Christensen
Presidentless than a yearUS$1.93msin datos
Herman Rosenman
Independent Director4.8yrsUS$149.64k0.29%
$ 62.2k
Kirk Malloy
Independent Director1.8yrsUS$136.64k0.013%
$ 2.8k
Matthew Posard
Independent Chairman of the Board7.8yrsUS$188.64k0.35%
$ 77.1k
Mark Capone
Independent Director1.8yrsUS$139.64k0.057%
$ 12.5k
Cynthia Collins
Independent Director4.8yrsUS$156.64k0.20%
$ 43.5k
Nathalie Keraudy
Independent Director2.6yrsUS$134.64k0.089%
$ 19.5k

2.6yrs

Permanencia media

56yo

Promedio de edad

Junta con experiencia: La junta directiva de DMTK no se considera experimentada (2.5 años de permanencia promedio), lo que sugiere una nueva junta directiva.